<DOC>
	<DOCNO>NCT03006016</DOCNO>
	<brief_summary>Hepatomegaly common morbidly obese patient may hamper access hiatal region bariatric surgery . The doctor make preliminary prospective study show preoperative 4-week course 1.500 Mg/ day without caloric restriction result 20 % reduction volume leave liver lobe ( segment 2 3 ) ultrasound . The aim study determine whether 4-week preoperative course omega-3 without caloric restriction ( 1650 mg omega-3 / day 4 week ) may reduce liver volume fat content , render thus surgery easy . The primary end point reduction volume leave liver lobe measure magnetic resonance imaging . Secondary end point : reduction whole liver volume , liver steatosis , liver injury surgery , duration surgery , evolution liver test well correlation preoperative MRI data intraoperative liver biopsy quantification liver steatosis . Study design : This interventional , prospective , multicentric , randomize , double blind clinical trial . Morbidly obese patient metabolic syndrome candidate bariatric surgery fulfil criterion bariatric surgery establish Haute Autorité de Santé elegible study . Number subject enrol : 44 patient 12 month . Study time schedule : At time enrollment visit two visit schedule , first begin study last end . Surgery schedule 7 day end treatment . At time two visit clinical examination perform avec calculation BMI , blood test ( ASAT , ALAT ; GGT , total , HDL LDL cholesterol , triglyceride , glycemia , C-peptide , HbA1c , insulin , HOMA-IR , C reactive protein ) MRI evaluate volume fat content liver . At time surgery duration surgery eventual liver injury record liver biopsy perform . The hypothesis , show preliminary study , omega-3 , result reduction volume leave liver lobe 20 % . Conclusion : If 4-week preoperative course omega-3 without caloric restriction result significant reduction liver volume steatosis bariatric surgery , may recommend systematic preoperative treatment .</brief_summary>
	<brief_title>Preoperative Omega-3 Polyunsaturated Fatty Acids Morbidly Obese Reduce Liver Volume Steatosis</brief_title>
	<detailed_description />
	<mesh_term>Obesity , Morbid</mesh_term>
	<criteria>Age 18 60 year Karnofsky Index de &gt; 70 BMI &gt; 35 kg/m2 associate metabolic syndrome define three follow : waistline measure least 80 centimeter european woman 94 centimeter european men ; High triglyceride level le 1.5 g/l specific medication ; Reduced highdensity lipoprotein ( HDL ) cholesterol le 1.04 mmol/L men le 1.3 mmol/L woman ; Increased blood pressure 130/85 millimeter mercury ( mm Hg ) high specific medication ; Elevated fast blood sugar 100 mg/dL ( 5.6 mmol/L ) high specific médications . Failure previous medical treatment morbid obesity well conduct multidisciplinary team least 6 month . Multidisciplinary team agreement bariatric surgery Patients affiliate French Health Care System ( Sécurité Sociale ) Patients sign informed consent Contraindications MRI ( pacemaker , metallic foreign body , claustrophobia ) Psychiatric contraindication bariatric surgery Anesthesiology contraindication surgery Progressive malignancy Chronic alcoholism ( &gt; 30 gr/day ) Uncontrolled sepsis History liver disease Renal failure ( Cockroft &lt; 30ml/min ) Long term treatment steroid Regular assumption alimentary complement enrich protein and/or amino acid ) Pregnancy ( pregnancy test do surgery fertile woman ) History bariatric surgery supramesocolic surgery render access hiatal region difficult . Forseeable difficulies complete followup Patients judicial protection Patients unable understand put practice medical prescription omega3 oral supplementation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>